Rising Incidence of Hemophilia, Immunological Disorders, and the Growing Number of Surgical Procedures Worldwide is Driving Growth, at a CAGR of ~9%< ...
The ambitious plans aim to secure medicine supply, accelerate innovation, strengthen clinical research, and reinforce IP ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema ...
Several years ago, a little-known drug named Ozempic — previously used only to treat diabetes — emerged as a promising new ...
Biogen Inc. (NASDAQ:BIIB), a leading biopharmaceutical company specializing in neurology and rare diseases, finds itself at a critical juncture as it navigates a complex landscape of opportunities and ...
In the United States, the biomedical industry encounters numerous regulatory challenges in conducting nonclinical and ...
Johnson & Johnson (NYSE: JNJ) has announced promising results from its pivotal Phase 3 Vivacity-MG3 study evaluating ...
ArisEurope, ICON, Syneos Health, Accenture, IQVIA, Genpact, Cognizant, Paraxel International, Laboratory Corporation of ...
Several years ago, a little-known drug named Ozempic—previously used only to treat diabetes—emerged as a promising new drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback